7/31/2013 6:32:19 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WASHINGTON, July 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the second quarter ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by